All Updates

All Updates

icon
Filter
Partnerships
SEQSTER partners with Antidote Technologies for clinical trial enrollment
Clinical Trial Technology
Jul 8, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Clinical Trial Technology

Clinical Trial Technology

Jul 8, 2024

SEQSTER partners with Antidote Technologies for clinical trial enrollment

Partnerships

  • SEQSTER, a healthcare data platform, has partnered with Antidote Technologies, a digital patient engagement company, to improve clinical trial enrollment and timelines.

  • Through the partnership, Antidote will leverage SEQSTER's data platform to match patients to clinical trials based on their genomic data, lifestyle factors, and medical history. This partnership aims to enhance Antidote's precision recruitment process, identify suitable participants more effectively, and reduce the time required to bring new treatments to market.

  • Based in California, SEQSTER is a healthcare technology company that focuses on providing real-time access to comprehensive health data, enabling the aggregation of disparate health data sources. Its enterprise operating system integrates electronic health records (EHRs), genomic data (DNA), wearable devices, pharmacy data, and social determinants of health (SDoH). SEQSTER’s platform creates longitudinal health records that facilitate efficient patient care, clinical research, and health data management.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.